Volume 5 Issue 2
Mar.  2014
Turn off MathJax
Article Contents
Cheng Jintao, Zhang Yingcai, Deng Yinan, et al. Effects of hepatocellular carcinoma-associated fibroblasts on differentiation of monocyte-derived dendritic cells[J]. ORGAN TRANSPLANTATION, 2014, 5(2): 107-112. doi: 10.3969/j.issn.1674-7445.2014.02.011
Citation: Cheng Jintao, Zhang Yingcai, Deng Yinan, et al. Effects of hepatocellular carcinoma-associated fibroblasts on differentiation of monocyte-derived dendritic cells[J]. ORGAN TRANSPLANTATION, 2014, 5(2): 107-112. doi: 10.3969/j.issn.1674-7445.2014.02.011

Effects of hepatocellular carcinoma-associated fibroblasts on differentiation of monocyte-derived dendritic cells

doi: 10.3969/j.issn.1674-7445.2014.02.011
  • Received Date: 2014-01-03
    Available Online: 2021-01-26
  • Publish Date: 2014-03-15
  • Objective To study the effects of hepatocellular carcinoma-associated fibroblasts(hCAF) on the differentiation of monocyte(Mo)-derived dendritic cell(DC). Methods The human hCAF were obtained from hepatic carcinoma tissue by enzyme digestion method. The healthy human peripheral blood mononuclear cells(PBMC) were prepared by density gradient centrifugation and CD14+Mo from healthy human peripheral white blood cells were purified by density gradient centrifugation and magnetic bead separation. hCAF-CD14+Mo(1:10) and CD14+Mo were treated by granulocyte-macrophage colony-stimulation factor(GM-CSF) (20 ng/ml) and interleukin(IL)-4 (20 ng/ml) which were added in day 1 and day 4 for 6 days. And then the cells of two groups were divided into two halves: one with or without the further stimulation of lipopolysaccharides(LPS, 200 ng/ml) for 3 days respectively. Finally the cells were divided into 4 groups: hCAF-Mo, hCAF-Mo+LPS, immature DC(iDC) and mature DC(mDC) group. Morphological changes of cells in 4 groups were observed by inverted fluorescence microscope. Cells in each group were divided into two parts. The expression of CD83,CD80, CD1a of cells in one part were detected by flow cytometry. And ability of T cells proliferation in the other part was analyzed by flow cytometry after co-culturing with CFSE-labeled T cells for 5 days. Results The result of inverted microscope showed that Mo couldn't differentiate into DC by the interference of hCAF. The expressions of CD83, CD1a and CD80 were (3.2±0.7)%,(61.7±8.4)%,(30.1±0.9)% respectively in iDC group,(80.2±2.8)%, (83.15±6.0)%,(96.1±1.9)% in mDC group,(1.6±0.9)%,(1.8±0.9)%,(16.0±3.2)% in hCAF-Mo group,(9.0±1.2)%、(1.1±0.4)%、(58.4±3.6)% in hCAF-Mo+LPS group. There was significant difference of the expressions of CD1a and CD80 between hCAF-Mo and iDC groups(both in P<0.01). Due to the extremely low expression of CD83 in iDC group, there was no significant difference between hCAF-Mo and iDC groups(P>0.05). There was significant difference of the expressions of CD83,CD1a and CD80 between hCAF-Mo+LPS and mDC groups (all in P<0.01). Proliferation rate of T cells were (3.3±0.9)% in iDC group, (34.5±7.3)% in mDC group,(5.3±1.2)% in hCAF-Mo group,(7.0±1.2)% in hCAF-Mo+LPS group. Compared with iDC group, mDC could promote the proliferation of T cells effectively. And the proliferation of T cells in hCAF-Mo and hCAF-Mo+LPS group was lower than that in mDC group(P<0.01). Conclusions hCAF can suppress the differentiation of Mo-derived DC, which may play an important role in immune escape of hepatocellular carcinoma.

     

  • loading
  • [1]
    Mazzocca A, Dituri F, Lupo L,et al.Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts[J]. Hepatology, 2011,54(3):920-930. doi: 10.1002/hep.24485
    [2]
    Jia CC, Wang TT, Liu W, et al. Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion[J]. PLoS One, 2013, 8(5):e63243. doi: 10.1371/journal.pone.0063243
    [3]
    汪田甜,贾昌昌,张琪,等. 肝癌相关成纤维细胞的培养和鉴定及其对肝癌细胞增殖的影响[J]. 吉林大学学报, 2012, 38(3):438-442. http://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201203014.htm

    Wang TT, Jia CC, Zhang Q,et al. Culture and identification of hepatocellular carcinoma associated fibroblasts and their effects on proliferation of hepatocellular carcinoma cells[J]. J Jilin Univ: Med Ed, 2012, 38(3):438-442. http://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201203014.htm
    [4]
    Mantovani A, Allavena P, Sica A,et al.Cancer-related inflammation[J].Nature, 2008, 454(7203):436-444. doi: 10.1038/nature07205
    [5]
    Hembruff SL, Jokar I, Yang L, et al. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms[J]. Neoplasia, 2010, 12(5):425-433. doi: 10.1593/neo.10200
    [6]
    Augsten M, Hägglöf C, Olsson E,et al.CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth[J]. Proc Natl Acad Sci U S A, 2009, 106(9):3414-3419. doi: 10.1073/pnas.0813144106
    [7]
    Kobayashi N, Miyoshi S, Mikami T,et al.Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization[J]. Cancer Res, 2010,70(18):7073-7083. doi: 10.1158/0008-5472.CAN-09-4687
    [8]
    Li T, Yang Y, Hua X,et al. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO[J]. Cancer Lett, 2012, 318(2):154-161. doi: 10.1016/j.canlet.2011.12.020
    [9]
    Su X, Ye J, Hsueh EC,et al.Tumor microenvironments direct the recruitment and expansion of human Th17 cells[J]. J Immunol, 2010, 184(3):1630-1641. doi: 10.4049/jimmunol.0902813
    [10]
    Nazareth MR, Broderick L, Simpson-Abelson MR,et al. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells[J]. J Immunol,2007,178(9):5552-5562. doi: 10.4049/jimmunol.178.9.5552
    [11]
    Barnas JL, Simpson-Abelson MR, Brooks SP, et al. Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors[J]. J Immunol, 2010, 185(5):2681-2692. doi: 10.4049/jimmunol.1000896
    [12]
    Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression[J]. Trends Immunol,2010, 31(6):220-227. doi: 10.1016/j.it.2010.04.002
    [13]
    van de Ven R, Lindenberg JJ, Oosterhoff D, et al. Dendritic cell plasticity in tumor-conditioned skin: CD14+ cells at the cross-roads of immune activation and suppression[J]. Front Immunol,2013,4:403.
    [14]
    马麟麟.免疫抑制剂对树突状细胞的影响[J].器官移植,2013,4(6):370-372. http://www.organtranspl.com/browse/detail/qkid/0/id/255.html

    Ma LL. Effect of immunosuppressive agents on the dendritic cell[J]. Organ Transplant,2013,4(6):370-372. http://www.organtranspl.com/browse/detail/qkid/0/id/255.html
    [15]
    Mailliard RB, Dallal RM, Son YI,et al.Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen[J].Immunol Invest,2000, 29(2):177-185. doi: 10.3109/08820130009062302
    [16]
    张海明,郑虹,邓永林,等.肝癌复发与未复发患者再次肝移植的预后分析[J].中华器官移植杂志,2013,34(7):407-410.

    Zhang HM, Zheng H, Deng YL, et al. Retransplantation of HCC patients with or without HCC recurrence[J]. Chin Organ Transplant,2013,34(7):407-410.
    [17]
    陈规划, 张琪. 干细胞在肝移植中的应用现状及展望[J/CD]. 中华肝脏外科手术学电子杂志, 2012, 1(2): 70-73.

    Chen GH, Zhang Q. Stem cell therapy in the liver transplantation[J/CD].Chin J Hapat Surg(Electronic Edition), 2012, 1(2): 70-73.
    [18]
    Reinhard G, Märten A, Kiske SM,et al.Generation of dendritic cell-based vaccines for cancer therapy[J]. Br J Cancer,2002, 86(10):1529-1533. doi: 10.1038/sj.bjc.6600316
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Article Metrics

    Article views (144) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return